The road to momentum

Vasella’s eureka moment

What does it take to make a CEO jump? Dr. Daniel Vasella, chairman of Novartis, one of the world’s largest pharmaceutical firms, found out in April 1999 when he was handed a report on a new drug developed by his oncology division. The results before his eyes were better than good – they were sensational. Vasella knew this drug would make a difference, not only to his company, but to cancer patients all over the world.

The report that electrified Vasella covered the first phase of research on a product then known as STI571, later renamed Glivec, developed to treat a form of cancer called chronic myelogenous leukaemia, or CML.1

At the time, there were about 40 000 known CML sufferers worldwide, with ...

Get The Momentum Effect now with O’Reilly online learning.

O’Reilly members experience live online training, plus books, videos, and digital content from 200+ publishers.